glp-1 obesity drug market size 2025 Receptor Agonists Drugs Size, Trends, Growth Report 2032 Oral Obesity Drugs Market Size
Description
Bibcode:1993BBRC..196..141G
Semaglutide was approved by the FDA on December 5, 2017
PMID: 38302593
Because these drugs are so revolutionary and there is little in the way of competition, people who can afford them are willing to pay a premium
2026 Jan 2;16:1702448
The downsides are real too
